Paclitaxel and suramin-loaded core/shell microspheres in the treatment of brain tumors

被引:76
作者
Nie, Hemin [1 ]
Fu, Yilong [1 ]
Wang, Chi-Hwa [1 ]
机构
[1] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117576, Singapore
关键词
Paclitaxel; Suramin; Microsphere; Drug delivery; Chemotherapy; In vivo; CONTROLLED DELIVERY; LOCAL CHEMOTHERAPY; PHASE-II; IN-VITRO; CARMUSTINE; MICROPARTICLES; NANOPARTICLES; GLIOBLASTOMA; IMPLANTS; EFFICACY;
D O I
10.1016/j.biomaterials.2010.07.080
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
This work presents a modified method, namely coaxial electrohydrodynamic atomization, for the preparation of microspheres with distinct core/shell structures. This allows the encapsulation of two drugs with different characteristics in hydrophilic properties in one single step. Variation of ratios between outer flow and inner flow produces polymer microspheres with different core/shell ratios, and consequently results in variable release rates of drugs. Significant changes in release patterns were demonstrated when the distributions of the two drugs in microspheres were swapped. Moreover, cell culture experiments and animal experiments have been carried out to testify the performances of different microspheres in cytotoxicity, cellular apoptosis in vitro and tumor inhibition against subcutaneous U87 glioma xenograft in BALB/c nude mice. These findings present the advantages and possible application of this kind of multi-drug release system in treating brain tumors. Moreover, the release rates and characteristic sequences of multi-drugs can be tailored and tuned according to treatment necessity and applied in treating other kinds of tumors. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:8732 / 8740
页数:9
相关论文
共 39 条
  • [1] Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug
    Ahmed, Fariyal
    Pakunlu, Refika I.
    Brannan, Aaron
    Bates, Frank
    Minko, Tamara
    Discher, Dennis E.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2006, 116 (02) : 150 - 158
  • [2] INTERSTITIAL CHEMOTHERAPY WITH DRUG POLYMER IMPLANTS FOR THE TREATMENT OF RECURRENT GLIOMAS
    BREM, H
    MAHALEY, S
    VICK, NA
    BLACK, KL
    SCHOLD, SC
    BURGER, PC
    FRIEDMAN, AH
    CIRIC, IS
    ELLER, TW
    COZZENS, JW
    KENEALY, JN
    [J]. JOURNAL OF NEUROSURGERY, 1991, 74 (03) : 441 - 446
  • [3] PLACEBO-CONTROLLED TRIAL OF SAFETY AND EFFICACY OF INTRAOPERATIVE CONTROLLED DELIVERY BY BIODEGRADABLE POLYMERS OF CHEMOTHERAPY FOR RECURRENT GLIOMAS
    BREM, H
    PIANTADOSI, S
    BURGER, PC
    WALKER, M
    SELKER, R
    VICK, NA
    BLACK, K
    SISTI, M
    BREM, S
    MOHR, G
    MULLER, P
    MORAWETZ, R
    SCHOLD, SC
    [J]. LANCET, 1995, 345 (8956): : 1008 - 1012
  • [4] CAHAN MA, 1994, CANCER CHEMOTH PHARM, V33, P441, DOI 10.1007/BF00686276
  • [5] AIDS-related central nervous system lymphomas
    Chamberlain, MC
    Kormanik, PA
    [J]. JOURNAL OF NEURO-ONCOLOGY, 1999, 43 (03) : 269 - 276
  • [6] Chang SM, 2001, CANCER, V91, P417, DOI 10.1002/1097-0142(20010115)91:2<417::AID-CNCR1016>3.0.CO
  • [7] 2-9
  • [8] SURAMIN INHIBITION OF GROWTH-FACTOR RECEPTOR-BINDING AND MITOGENICITY IN AKR-2B CELLS
    COFFEY, RJ
    LEOF, EB
    SHIPLEY, GD
    MOSES, HL
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1987, 132 (01) : 143 - 148
  • [9] Preparation and characterization of carmustine loaded polyanhydride wafers for treating brain tumors
    Domb, AJ
    Israel, ZH
    Elmalak, O
    Teomim, D
    Bentolila, A
    [J]. PHARMACEUTICAL RESEARCH, 1999, 16 (05) : 762 - 765
  • [10] Fang GF, 1998, CANCER RES, V58, P3202